The Hindu Business Line : Ranbaxy’s AIDS drug gets WHO nod

Ranbaxy Laboratories has said it has received the pre-qualification from the World Health Organisation for its anti- retroviral capsule ‘Indinavir’. Pre-qualifications are needed to become eligible for exporting drugs to WHO-sponsored programmes. Anti-retroviral drugs are used in the treatment of person having HIV/AIDS infections. With this new addition, Ranbaxy now has a total of 19 anti-retrovirals ARVs on the WHO pre-qualification list. “Ranbaxy remain s committed to provide high quality affordable generic ARV medicines and will continue to dedicate itself in fighting the worldwide struggle against HIV/AIDS,” the Ranbaxy CEO and Managing Director, Mr Atul Sobti, said. —

Our Bureau

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
SC to hear Zenotech case on Dec 2

Kirloskar Oil Engines to exit six joint ventures

ONGC-Mittal ventures to be merged

Big business matters

Nano: Compensation issues resolved

L&T sets up tower testing facility

Mahindra Lifespace puts up new residential project

Steel Strips to study feasibility of wheel rim plant in Morocco

Cabinet nod for OVL’s additional investment in Brazil

Ranbaxy’s AIDS drug gets WHO nod

Aurobindo gets US nod for drug

Management meet

Bajaj puts in place new growth strategy for bikes

Benz sees lower sales in 2009

Exide eyes bigger pie of tractor battery market